Please Wait a Moment
X

Articles

08Sep

Dr. Marion Lanteri Joins Creative Testing Solutions as Scientific Affairs VP

08 Sep, 2022 | Return|

TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solutions’ vice president of scientific affairs. CTS is a leading research partner, tracking infectious disease markers in the national blood supply, among many other significant projects. As the largest nonprofit blood and plasma laboratory organization in the world, CTS exists to ensure the safety of blood and plasma-derived products for life-saving transfusion and therapeutic use.

Lanteri will lead all CTS’s scientific activities, clinical trials, research, data collection, analysis, and publication in this first-ever dedicated role for CTS.

“Blood transfusions and blood derivatives are integral to patient’s healthcare. Blood screening plays a critical role in blood safety, of which blood donor research is a key component of this process,” says Lanteri. “I am honored to continue to serve as a leader in this important endeavor, something I’ve strived to do over my nearly 20-year career.”

Lanteri’s experience includes 12 years with Vitalant Research Institute in San Francisco. She began there as a post-doctoral student researching immunology and specializing in West Nile, dengue, and Zika virus research and in pathogen inactivation. She has and continues to serve as an assistant adjunct professor at the University of California San Francisco Department of Laboratory Medicine.

Lanteri holds a doctorate in molecular biology and virology, specifically studying HIV at the University of Nice Sophia-Antipolis in France. She is a member of the American Society for Virology, the Association for the Advancement of Blood and Biotherapies, and the International Society of Blood Transfusion. Lanteri has authored or co-authored over 60 peer-reviewed publications.

About Creative Testing Solutions

Creative Testing Solutions provides high-volume donor testing for over 22 million blood and plasma donations annually and tests samples of each unit for all of the viral marker and screening tests required by the Food and Drug Administration. CTS is the world's largest nonprofit blood and plasma donor testing laboratory organization, partnering with over 100 healthcare entities. Our more than 1,000 team members reside remotely or in eight testing labs in Austin, Texas; Phoenix, Arizona; Dallas, Texas; Tampa, Florida; Charlotte, Memphis, Tennessee; North Carolina; St. Louis, Missouri; and San Marcos, Texas. CTS is a 501(c)(3) organization governed by a board of 11 directors.

 

 

 

 

Related

Exhibiting at AABB Annual Meeting- Booth 732

We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...

Read More >

MD Revised Headers on CTS forms

Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...

Read More >

Seasonal Monitoring for WNV to begin June 1, 2020

Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...

Read More >

CTS implements Ultrio Plus on the Panther

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...

Read More >

CTS to Implement Licensed Babesia testing

In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols  ...

Read More >

Reminder-New Learning Center with New Content Launches on March 30!

The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...

Read More >